PT1147119E - Derivados 2,3-o-isopropilideno de monossacaridos como inibidores de adesao celular - Google Patents

Derivados 2,3-o-isopropilideno de monossacaridos como inibidores de adesao celular

Info

Publication number
PT1147119E
PT1147119E PT00900088T PT00900088T PT1147119E PT 1147119 E PT1147119 E PT 1147119E PT 00900088 T PT00900088 T PT 00900088T PT 00900088 T PT00900088 T PT 00900088T PT 1147119 E PT1147119 E PT 1147119E
Authority
PT
Portugal
Prior art keywords
monosacaridos
cell adhesion
adhesion inhibitors
isopropylidene derivatives
isopropylidene
Prior art date
Application number
PT00900088T
Other languages
English (en)
Portuguese (pt)
Inventor
Sudershan K Arora
Nawal Kishore
Jang Bahadur Gupta
Vishwas D Joshi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of PT1147119E publication Critical patent/PT1147119E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT00900088T 1999-01-15 2000-01-10 Derivados 2,3-o-isopropilideno de monossacaridos como inibidores de adesao celular PT1147119E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (enExample) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors

Publications (1)

Publication Number Publication Date
PT1147119E true PT1147119E (pt) 2004-02-27

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00900088T PT1147119E (pt) 1999-01-15 2000-01-10 Derivados 2,3-o-isopropilideno de monossacaridos como inibidores de adesao celular

Country Status (30)

Country Link
US (5) US6590085B1 (enExample)
EP (1) EP1147119B1 (enExample)
JP (1) JP2002534530A (enExample)
CN (1) CN1167707C (enExample)
AR (1) AR022235A1 (enExample)
AT (1) ATE250074T1 (enExample)
AU (1) AU768511B2 (enExample)
BG (1) BG105745A (enExample)
BR (1) BR0007553A (enExample)
CA (1) CA2359986A1 (enExample)
CO (1) CO5180591A1 (enExample)
CR (1) CR6423A (enExample)
CZ (1) CZ20012540A3 (enExample)
DE (1) DE60005300T2 (enExample)
DK (1) DK1147119T3 (enExample)
ES (1) ES2206176T3 (enExample)
HR (1) HRP20010529B1 (enExample)
HU (1) HUP0105116A3 (enExample)
ID (1) ID30351A (enExample)
IN (1) IN190975B (enExample)
MA (1) MA25342A1 (enExample)
MX (1) MXPA01007187A (enExample)
MY (1) MY121135A (enExample)
NZ (2) NZ512852A (enExample)
PA (1) PA8489901A1 (enExample)
PT (1) PT1147119E (enExample)
SK (1) SK284241B6 (enExample)
TR (1) TR200102043T2 (enExample)
WO (1) WO2000042054A1 (enExample)
YU (1) YU50701A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
SG141430A1 (en) 2003-05-30 2008-04-28 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
EP1789428A1 (en) * 2004-09-02 2007-05-30 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20100113371A9 (en) * 2004-12-22 2010-05-06 Ranbaxy Laboratories Limited Inc. Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
EP1915160A2 (en) * 2005-07-22 2008-04-30 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
US20080114031A1 (en) * 2006-03-29 2008-05-15 Sattigeri Viswajanani J Monosaccharide derivatives
US7790689B2 (en) * 2006-05-30 2010-09-07 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives
US10034995B2 (en) * 2007-09-20 2018-07-31 Resmed Limited Retractable tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
AU768511B2 (en) 2003-12-18
US6590085B1 (en) 2003-07-08
HK1041270A1 (en) 2002-07-05
ID30351A (id) 2001-11-22
NZ512852A (en) 2004-02-27
TR200102043T2 (tr) 2001-11-21
US20040023900A1 (en) 2004-02-05
HRP20010529B1 (en) 2005-02-28
CO5180591A1 (es) 2002-07-30
CN1343213A (zh) 2002-04-03
WO2000042054A1 (en) 2000-07-20
MY121135A (en) 2005-12-30
HUP0105116A2 (hu) 2003-04-28
US7037899B2 (en) 2006-05-02
JP2002534530A (ja) 2002-10-15
CR6423A (enExample) 2004-03-09
DE60005300D1 (de) 2003-10-23
YU50701A (sh) 2005-06-10
EP1147119A1 (en) 2001-10-24
BG105745A (en) 2002-05-31
US7005516B2 (en) 2006-02-28
MXPA01007187A (es) 2002-04-24
SK10132001A3 (sk) 2002-01-07
AU1886100A (en) 2000-08-01
ATE250074T1 (de) 2003-10-15
US7005422B2 (en) 2006-02-28
DK1147119T3 (da) 2004-01-19
ES2206176T3 (es) 2004-05-16
PA8489901A1 (es) 2000-09-29
HUP0105116A3 (en) 2003-05-28
CZ20012540A3 (cs) 2002-02-13
AR022235A1 (es) 2002-09-04
DE60005300T2 (de) 2004-07-15
NZ527483A (en) 2005-02-25
CN1167707C (zh) 2004-09-22
SK284241B6 (en) 2004-11-03
US20040019191A1 (en) 2004-01-29
CA2359986A1 (en) 2000-07-20
US20040018995A1 (en) 2004-01-29
HRP20010529A2 (en) 2002-08-31
BR0007553A (pt) 2001-12-18
MA25342A1 (fr) 2001-12-31
US20040029820A1 (en) 2004-02-12
EP1147119B1 (en) 2003-09-17
IN190975B (enExample) 2003-09-06

Similar Documents

Publication Publication Date Title
PT1042287E (pt) Derivados de indole como inibidores do factor xa
PT1084114E (pt) Derivados isotiazole uteis como agentes anticancerigenos
DE60010448D1 (de) Amid-derivate
NO20022573L (no) N6-heterosykliske, 8-modifiserte adenosinderivater
PT1177185E (pt) Derivados de 4, 5, 6, 7-tetra-hidroindazole como agentes antitumorais
PT1185529E (pt) Pirazolobenzodiazepinas como inibidores de cdk2
PT1165516E (pt) Ureia heterociclica e compostos relacionados, uteis como agentes anti-inflamatorios
PT1144425E (pt) Derivados de monossacaridos como inibidores de adesao celular
PT1060178E (pt) Compostos heterociclicos como inibidores de enzimas rotamase
PT1379511E (pt) Derivados de di-hidro-benzo[b] [1,4] diazepin-2-ona como antagonistas ii de r2glum
AR028576A1 (es) Derivados de b-carbolina utiles como inhibidores de fosfodiesterasa
PT1220831E (pt) Novos derivados eter biarilico uteis como inibidores de recaptacao de monoamina
DK1218382T3 (da) Bicykliske imidazo-3-ylaminderivater
PT1212320E (pt) Fenilpiperazinas como inibidores de reabsorcao de serotonina
DE60022450D1 (de) Batteriehalterung
DE60045759D1 (de) Amid-verbindungen
DE50015443D1 (de) Bicyclische imidazo-5-yl-aminderivate
MXPA03001848A (es) Derivados de fenoxibencilamina como inhibidores de la reabsorcion de serotonina.
PT1226143E (pt) Derivados de imidazopiridina como inibidores da fosfodiesterase vii
PT1246810E (pt) Piperidiniloxi- e pirrolidiniloxifeniloxazolidinonas como antibacterianos
PT1189907E (pt) Tienopirimidinas como inibidores da fosfodiesterase
PT1155013E (pt) Compostos heterociclicos de benzenossulfonamida como antagonistas da bradiquinina
PT1154988E (pt) Derivados de mevinolina
PT1216250E (pt) Derivados propilicos substituidos de tienoisoxazolil- e tienilpirrazolil-fenoxi uteis como antagonistas d4
ATE262528T1 (de) Substituierte purine-derivate als zell- adhäsionhemmer